| Application no. and date | 22206709.2 (espacenet) (Federated) (European Patent Register), 20180427 | | Patent/reg. no. and date | DK/EP 4190355, 20240925 | | Publication date | 20230607 | | Priority no. and date | US 201762492056 P, 20170428 | | EP pub. no. and date |
EP 4190355 20230607 | | Effective date | | | Applicant/owner | Amgen Inc., One Amgen Center Drive
Thousand Oaks, CA 91320-1799, US | | Applicant ref. no. | 639998 | | Inventor | BRYCH, Stephen Robert,
Thousand Oaks 91362, US,
WONG, Lyanne M.,
Valencia 91354, US,
FALLON, Jaymille,
Agoura Hills 91301, US,
GOSS, Monica Michelle,
Newbury Park 91320, US,
GU, Jian, Hua,
Thousand Oaks 91320, US,
GHATTYVENKATAKRISHNA, Pavan K.,
Cambridge 02142, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , C07K 16/28 (2006.01) | | Title | FORMULERINGER AF HUMANE ANTI-RANKL-ANTISTOFFER OG FREMGANGSMÅDER TIL ANVENDELSE DERAF | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
